Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2517 | 3370 | 29.8 | 63% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
67 | 85549 | INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS//MRSA |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1546 | 2517 | FEBRILE NEUTROPENIA//NEUTROPENIA//NEUTROPENIC FEVER |
22618 | 319 | SEGMENTED FILAMENTOUS BACTERIA//CANDIDATUS ARTHROMITUS//PUTREFACTIVE PRODUCTS |
27723 | 182 | CARBOXYLATE PLATFORM//MIXALCO PROCESS//MIXALCO TM PROCESS |
29234 | 156 | BACTERIAL FLUORESCENCE//BIASE//DISTANT RECOGNITION |
31870 | 117 | BIOTECHNOLOGY AGENTS//BACTERIOL IMMUNOL DEV//COMMAND ENGN CHEM DEF |
34057 | 79 | ADHERENT BACTERIA//RUMEN MUCOSA//SIMONSIELLA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | Author keyword | 148 | 42% | 8% | 275 |
2 | NEUTROPENIA | Author keyword | 57 | 14% | 11% | 364 |
3 | SEGMENTED FILAMENTOUS BACTERIA | Author keyword | 36 | 71% | 1% | 29 |
4 | CARBOXYLATE PLATFORM | Author keyword | 30 | 84% | 0% | 16 |
5 | NEUTROPENIC FEVER | Author keyword | 24 | 42% | 1% | 44 |
6 | CANDIDATUS ARTHROMITUS | Author keyword | 21 | 90% | 0% | 9 |
7 | FEVER AND NEUTROPENIA | Author keyword | 19 | 74% | 0% | 14 |
8 | MIXALCO PROCESS | Author keyword | 15 | 82% | 0% | 9 |
9 | FEVER IN NEUTROPENIA | Author keyword | 12 | 86% | 0% | 6 |
10 | MIXALCO TM PROCESS | Author keyword | 11 | 100% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | 148 | 42% | 8% | 275 | Search FEBRILE+NEUTROPENIA | Search FEBRILE+NEUTROPENIA |
2 | NEUTROPENIA | 57 | 14% | 11% | 364 | Search NEUTROPENIA | Search NEUTROPENIA |
3 | SEGMENTED FILAMENTOUS BACTERIA | 36 | 71% | 1% | 29 | Search SEGMENTED+FILAMENTOUS+BACTERIA | Search SEGMENTED+FILAMENTOUS+BACTERIA |
4 | CARBOXYLATE PLATFORM | 30 | 84% | 0% | 16 | Search CARBOXYLATE+PLATFORM | Search CARBOXYLATE+PLATFORM |
5 | NEUTROPENIC FEVER | 24 | 42% | 1% | 44 | Search NEUTROPENIC+FEVER | Search NEUTROPENIC+FEVER |
6 | CANDIDATUS ARTHROMITUS | 21 | 90% | 0% | 9 | Search CANDIDATUS+ARTHROMITUS | Search CANDIDATUS+ARTHROMITUS |
7 | FEVER AND NEUTROPENIA | 19 | 74% | 0% | 14 | Search FEVER+AND+NEUTROPENIA | Search FEVER+AND+NEUTROPENIA |
8 | MIXALCO PROCESS | 15 | 82% | 0% | 9 | Search MIXALCO+PROCESS | Search MIXALCO+PROCESS |
9 | FEVER IN NEUTROPENIA | 12 | 86% | 0% | 6 | Search FEVER+IN+NEUTROPENIA | Search FEVER+IN+NEUTROPENIA |
10 | MIXALCO TM PROCESS | 11 | 100% | 0% | 6 | Search MIXALCO+TM+PROCESS | Search MIXALCO+TM+PROCESS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRANULOCYTOPENIC PATIENTS | 237 | 72% | 6% | 186 |
2 | CEFTAZIDIME PLUS AMIKACIN | 164 | 82% | 3% | 94 |
3 | EMPIRIC THERAPY | 113 | 71% | 3% | 91 |
4 | MULTINATIONAL ASSOCIATION | 87 | 79% | 2% | 56 |
5 | PLUS AMIKACIN | 79 | 88% | 1% | 37 |
6 | EARLY HOSPITAL DISCHARGE | 69 | 61% | 2% | 73 |
7 | LOW RISK NEUTROPENIA | 51 | 91% | 1% | 21 |
8 | NEUTROPENIC PATIENTS | 49 | 17% | 8% | 269 |
9 | FEBRILE NEUTROPENIA | 48 | 25% | 5% | 166 |
10 | GRANULOCYTOPENIC CANCER PATIENTS | 46 | 67% | 1% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | 2002 | 1046 | 145 | 64% |
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever | 1997 | 414 | 160 | 75% |
Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients | 2005 | 192 | 94 | 94% |
Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance | 2013 | 34 | 48 | 58% |
GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER | 1990 | 357 | 116 | 81% |
MANAGEMENT OF FEVER IN PATIENTS WITH CANCER AND TREATMENT-INDUCED NEUTROPENIA | 1993 | 593 | 88 | 34% |
Antibiotic prophylaxis in neutropenic patients - New evidence, practical decisions | 2006 | 68 | 37 | 76% |
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis | 2007 | 43 | 51 | 98% |
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) | 2013 | 18 | 58 | 59% |
The current spectrum of infection in cancer patients with chemotherapy related neutropenia | 2014 | 8 | 54 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOCOMPROMISED HOST DIS UNIT | 6 | 100% | 0.1% | 4 |
2 | FLORIDA RENEWABLE CHEM FUELS | 3 | 100% | 0.1% | 3 |
3 | FLORIDA RENEWABLE CHEM FUELS FCRC | 3 | 100% | 0.1% | 3 |
4 | REIPI SPANISH NETWORK INFECT DIS | 3 | 50% | 0.1% | 4 |
5 | MANITOBA BLOOD MARROW TRANSPLANT PROGRAMME | 3 | 60% | 0.1% | 3 |
6 | PEDIAT ADOLESCENT COMPARAT EFFECTIVENESS | 2 | 67% | 0.1% | 2 |
7 | PROGRAM MICROBIOL MYCOL | 2 | 67% | 0.1% | 2 |
8 | PROGRAM POPULAT GENOM | 1 | 31% | 0.1% | 4 |
9 | CIBE INVEST BIOMED RED ENFERMEDADES P | 1 | 100% | 0.1% | 2 |
10 | IMMUNOCOMPROMISED HOST PROGRAM | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000019023 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
2 | 0.0000017818 | ORAL MUCOSITIS//MUCOSITIS//WIEDEMANN RAUTENSTRAUCH SYNDROME |
3 | 0.0000015772 | BLOOD CULTURE//BLOOD CULTURES//TIME TO POSITIVITY |
4 | 0.0000010880 | OPAT//HOSPITAL AT HOME//OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY OPAT |
5 | 0.0000009836 | ASPERGILLOSIS//VORICONAZOLE//AMPHOTERICIN B |
6 | 0.0000008795 | ANTIBIOTIC USE//ANTIMICROBIAL STEWARDSHIP//ANTIBIOTIC RESISTANCE |
7 | 0.0000008476 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
8 | 0.0000008269 | GROUP B STREPTOCOCCUS//PROCALCITONIN//NECROTIZING ENTEROCOLITIS |
9 | 0.0000007009 | VASCULAR ACCESS//JOURNAL OF VASCULAR ACCESS//CENTRAL VENOUS CATHETER |
10 | 0.0000006102 | CLOSTRIDIUM DIFFICILE//CLOSTRIDIUM PERFRINGENS//CLOSTRIDIUM DIFFICILE INFECTION |